Mortality Benefit of Immediate Revascularization of Acute ST-Segment Elevation Myocardial Infarction in Patients With Contraindications to Thrombolytic Therapy
Open Access
- 8 October 2003
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (14) , 1891-1898
- https://doi.org/10.1001/jama.290.14.1891
Abstract
Thrombolytic therapy is the most widely used method of achieving coronary artery reperfusion in patients with acute ST-segment elevation myocardial infarction (STEMI).1,2 Evidence shows that percutaneous coronary intervention may be more effective than thrombolytic therapy, but this treatment is limited to institutions capable of 24-hour cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery.3-6 The 1999 American College of Cardiology/American Heart Association (ACC/AHA) guidelines classified mechanical reperfusion as a class IIA recommendation (conflicting evidence but weight in favor of efficacy) for managing acute myocardial infarction (AMI) in patients with STEMI who have contraindications to thrombolytic therapy.4Keywords
This publication has 0 references indexed in Scilit: